NL-OMON55094招募中不适用
COVID-19 patients with severe or fatal outcome have a pre-existing state of immune-aging; exploring determinants of disease - Pre-existing immune-aging in COVID-19
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 152
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Suspected of COVID-19
- •Age * 18 years
- •Providing informed consent after reading patient information
排除标准
- •Insufficient knowledge of Dutch
- •No signed informed consent
研究者
相似试验
尚未招募
不适用
ower morbidity and mortality in COVID-19 patients admitted in a dedicated COVID Hospital of Odisha - A Radiological perspectiveCTRI/2020/08/027247Dr Roopak Dubey
尚未招募
不适用
Clinical profile and outcome in COVID-19 positive cases in rural population.CTRI/2021/02/031115o
尚未招募
不适用
The outcome of Remdesivir and Tocilizumab in COVID 19.CTRI/2021/01/030341Seth G S Medical College and KEM Hospital Mumbai
已完成
不适用
Severe SARS-COV-2 (COVID-19) related disease in low and middle income country children aged 0-19 years: a multicountry cohort study in a network of hospitalsACTRN12621001154897World Health Organization, Department of Maternal and Child Health3,000
进行中（未招募）
不适用
Acupuncture treatment of people with residual symptoms of COVID-19 infectioSequelae of other specified infectious and parasitic diseasesB34.2RBR-29bt5qtHospital do Servidor Público Municipal